Identification of two genes associated with metastatic prostate cancer.

被引：0
|
作者：
Schwab, ED [1 ]
Pienta, KJ [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF UROLOGY | 1998年 / 159卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [21] Heterogeneous bone histomorphometric patterns in metastatic prostate cancer.
    Roudier, MP
    Sherrard, DJ
    True, LD
    Ott-Ralph, SM
    Meligro, C
    Berrie, M
    Soo, CCY
    Felise, DG
    Quinn, JE
    Vessella, RL
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S567 - S567
  • [22] Study of the immuno-microenvironment in metastatic prostate cancer.
    Gannon, P
    Bellon-Gagnon, P
    Lapointe, R
    Mes-Masson, AM
    Saad, F
    JOURNAL OF UROLOGY, 2005, 173 (04): : 115 - 115
  • [23] Use of hormonal therapy in men with metastatic prostate cancer.
    Lu-Yao, GL
    Moore, DF
    Dipaola, RS
    Yao, SL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 392S - 392S
  • [24] The use of bisphosphonates in the management of bone metastatic prostate cancer.
    Mercadante S.
    Current Urology Reports, 2002, 3 (3) : 244 - 249
  • [25] Inpatient outcomes of pathological fractures in metastatic prostate cancer.
    Ahuja, Kriti
    Lingamaneni, Prasanth
    Laswi, Hisham
    Kumi, Dennis Danso
    Chhabra, Navika
    Darweesh, Omnia
    Batra, Kunnal
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Management of prostate cancer. Part 3: metastatic disease
    Shah, Jyoti
    Khakar, Sara Jane
    Sooriakumaran, Prasanna
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (05) : 813 - 821
  • [27] Differential treatment response of prostate and metastatic lesions in patients with newly diagnosed metastatic prostate cancer.
    Esen, Baris
    Seymen, Hulya
    Falay, Okan
    Tarim, Kayhan
    Kilic, Mert
    Bavbek, Sevil
    Kordan, Yakup
    Tilki, Derya
    Esen, Tarik
    Demirkol, Mehmet Onur
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [28] Identification of quality care indicators in prostate cancer.
    Guillem, Vicente
    Rubio, Eduardo Diaz
    Camps, Carlos
    Cassinello, Javier
    Castellano, Daniel E.
    Carrato, Alfredo
    Gascon, Pedro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08)
  • [29] Identification of conditions of lapatinib effectiveness in prostate cancer.
    Jathal, Maitreyee K.
    Mooso, Benjamin A.
    D'Abronzo, Leandro S.
    Siddiqui, Salma
    Chen, Liqun
    van Spyck, Elyse
    Madhav, Anisha
    Ghosh, Paramita M.
    CANCER RESEARCH, 2013, 73 (08)
  • [30] Identification of novel ligands specific to prostate cancer.
    Aggarwal, S
    Denmeade, S
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6251S - 6251S
12345